v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets    
Cash $ 8,731 $ 6,219
Prepaid expenses and other current assets 692 328
Total current assets 9,423 6,547
Other assets 691 693
Total assets 10,114 7,240
Current liabilities    
Accounts payable 4,157 2,353
Accrued expenses and other current liabilities 1,523 1,386
Senior secured convertible notes at fair value 20,663 8,139
Total liabilities 26,343 11,878
COMMITMENTS AND CONTINGENCIES (NOTE 7)
Stockholders' Equity (Deficit)    
Common stock, par value $0.001; 100,000 shares authorized; 44,134 and 40,479 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 44 41
Additional paid-in capital 50,896 47,554
Accumulated deficit (68,259) (53,715)
Total PAVmed Inc. Stockholders' Deficit (14,996) (3,824)
Noncontrolling interest (1,232) (814)
Total Stockholders' Deficit (16,229) (4,638)
Total Liabilities and Equity (Deficit) 10,114 7,240
Series B Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred stock, par value $0.001, 20,000 shares authorized; $ 2,322 $ 2,296

Source